You appear to be offline. Some data may be unavailable until your connection is restored.
Description
AbbVie Inc. is a research‑focused biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines and biologics. Its portfolio spans immunology drugs such as Humira, Skyrizi and Rinvoq, oncology therapies including Imbruvica and Venclexta, neuroscience products like Vraylar and migraine treatments, as well as aesthetics brands such as Botox. AbbVie operates in the global pharmaceutical and healthcare sector, emphasizing innovative therapies for complex, chronic diseases. The firm is regarded as a leading U.S. biotech firm, noted for its blockbuster immunology franchise and a growing pipeline across multiple therapeutic areas.
Price Chart
Chart data not available
Price ChartPrice: Adjusted price over time.Total return %: Total return including dividends.Moving averages: Shows trends over time with 50-day and 200-day moving averages.Compare SPY: Benchmark performance against the S&P 500 index.
Never miss a move in ABBV
Set alerts for price targets, percentage moves, trailing stops, market open and close prices, after-hours and pre-market changes, new 52-week highs and lows, and more. Get notified the moment they happen.